Clinical evidence that more precisely defined dose distributions will improve cancer survival and decrease morbidity [1]

Medical Physics

Volumn 30, Issue 6, 2003, Pages 1281-1282

  Keall, Paul J ^a   Williamson, Jeffrey F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOSE DISTRIBUTIONS;

DISEASES;

CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; DOSE RESPONSE; EVIDENCE BASED MEDICINE; LETTER; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RADIATION DOSE; TECHNOLOGY;

EID: 0038038869     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1570371     Document Type: Letter

References (17)

1. R. J. Schulz and A. R. Kagan, "More precisely defined dose distributions are unlikely to affect cancer mortality," Med. Phys. 30, 276 (2003).
2. B. Fisher, S. Anderson, C. K. Redmond, N. Wolmark, D. L. Wickerham, and W. M. Cronin, "Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer," N. Engl. J. Med. 333, 1456-1461 (1995).
3. G. Liljegren, L. Holmberg, J. Bergh, A. Lindgren, L. Tabar, H. Nordgren, and H. O. Adami, "10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial," J. Clin. Oncol. 17, 2326-2333 (1999).
4. R. M. Clark, T. Whelan, M. Levine, R. Roberts, A. Willan, P. McCulloch, M. Lipa, R. H. Wilkinson, and L, J. Mahoney, "Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. Ontario Clinical Oncology Group," J. Natl. Cancer Inst. 88, 1659-1664 (1996).
5. U. Veronesi et al., "Radiotherapy after breast-preserving surgery in women with localized cancer of the breast," N. Engl. J. Med. 328, 1587-1591 (1993).
6. C. A. Perez, M. Bauer, S. Edelstein, B. W. Gillespie, and R. Birch, "Impact of tumor control on survival in carcinoma of the lung treated with irradiation," Int. J. Radiat. Oncol., Biol., Phys. 12, 539-547 (1986).
7. N. C. Choi and J. A. Doucette, "Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach," Cancer 48, 101-109 (1981).
8. M. K. Martel, R. K. Ten Haken, M. B. Hazuka, M. L. Kessler, M. Strawderman, A. T. Turrisi, T. S. Lawrence, B. A. Fraass, and A. S. Lichter, "Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients," Lung Cancer 24, 31-37 (1999).
9. P. Okunieff, D. Morgan, A. Niemierko, and H. D. Suit, "Radiation dose-response of human tumors," Int. J. Radiat. Oncol., Biol., Phys. 32, 1227-1237 (1995).
10. C. A. Perez, K. Stanley, P. Rubin, S. Kramer, L. Brady, R. Perez-Tamayo, G. S. Brown, J. Concannon, M. Rotman, and H. G. Seydel, "A prospecfive randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group," Cancer 45, 2744-2753 (1980).
11. C. A. Perez, T. F. Pajak, P. Ruhin, J. R. Simpson, M. Mohiuddin, L. W. Brady, R. Perez-Tamayo, and M. Rotman, "Long-term observations of the patterns of failure in patients with unresectahle non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group," Cancer 59, 1874-1881 (1987).
12. S. L. Kwa, J. V. Lebesque, J. C. Theuws, L. B. Marks, M. T. Munley, G. Bentel, D. Oetzel, U. Spahn, M. V. Graham, R. E. Drzymala, J. A. Purdy, A. S. Lichter, M. K. Martel, and R. K. Ten Haken, "Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients," Int. J. Radiat. Oncol., Biol., Phys. 42, 1-9 (1998).
13. M. V. Graham, J. A. Purdy, B. Emami, W. Harms, W. Bosch, M. A. Lockett, and C. A. Perez, "Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)," Int. J. Radiat. Oncol., Biol., Phys. 45, 323-329 (1999).
14. M. L. Hernando, L. B. Marks, G. C. Bentel, S. M. Zhou, D. Hollis, S. K. Das, M. Fan, M. T. Munley, T. D. Shafman, M. S. Anscher, and P. A. Lind, "Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer," Int. J. Radiat. Oncol., Biol., Phys. 51, 650-659 (2001).
15. D. Oetzel, P. Schraube, F. Hensley, G. Sroka-Perez, M. Menke, and M. Flentje, "Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis," Int. J. Radiat. Oncol., Biol., Phys. 33, 455-460 (1995).
16. Y. Seppenwoolde, J. V. Lebesque, K. de Jaeger, J. S. Belderbos, L. J. Boersma, C. Schilstra, G. T. Henning, J. A. Hayman, M. K. Martel, and R. K. Ten Haken, "Comparing different NTCP models that predict the incidence of radiation pneamonitis," Int. J. Radiat. Oncol., Biol., Phys. 55, 724-735 (2003).
17. E. D. Yorke, A. Jackson, K. E. Rosenzweig, S. A. Merrick, D. Gabrys, E. S. Venkatraman, C. M. Burman, S. A. Leibel, and C. C. Ling, "Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy," Int. J. Radiat. Oncol., Biol., Phys. 54, 329-339 (2002).